Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | FRPT | JBS |
|---|---|---|
| Price | $61.33 | $11.89 |
| Change today | ▲ 1.78% | ▲ 1.89% |
| Market cap | $2.95B | $39.12B |
| Return, 3 months | +12.5% | -2.5% |
| Return, year to date | +0.7% | -11.1% |
| Return, 1 year | +15.2% | -5.6% |
| P/E (TTM) | 15.9 | 11.1 |
| P/B | 2.4 | 4.8 |
| P/E percentile vs own 5y | 57th | 70th |
| Dividend yield | – | 8.41% |
| Revenue growth (YoY, latest qtr) | +13.0% | +13.8% |
| Net profit growth (YoY) | +196.5% | -116.2% |
| Gross margin | 40.8% | 11.8% |
| Operating margin | 6.9% | 3.7% |
| Net margin | 12.6% | 1.2% |
| Return on equity | – | 13.4% |
| Analyst target vs. price | +33.2% | +55.1% |
| Analyst buy share | 70% | 100% |
| RSI (14) | 46 | 46 |
| 30-day volatility | 28.7% | 32.0% |
| Max drawdown, 1 year | -44.6% | -36.5% |
| Trend read | Leaning bullish | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
